Literature DB >> 3530532

Measurement of urinary retinol-binding protein by enzyme-linked immunosorbent assay, and its application to detection of tubular proteinuria.

M D Topping, H W Forster, C Dolman, C M Luczynska, A M Bernard.   

Abstract

An enzyme-linked immunosorbent assay (ELISA) for urinary retinol-binding protein (RBP) has been developed and compared with urinary beta 2-microglobulin for the detection of tubular proteinuria. The assay has a working range of 10 to 250 micrograms of RBP per liter of urine. The within-assay CV was 3.2-7.1%, the between-assay CV 12.5%. A control population of 118 male subjects gave a geometric mean urinary RBP concentration of 7.7 micrograms per millimole of creatinine and a 95th centile of 22 micrograms per millimole of creatinine. Comparison of urinary RBP and beta 2-microglobulin concentrations in 80 control subjects and 117 subjects exposed to cadmium fumes gave correlations of r = 0.59 and 0.91, respectively. Of the 117 subjects exposed to cadmium fumes, 103 gave both RBP and beta 2-microglobulin concentrations on the same side of the upper 95th centile values of 22 and 38 micrograms per millimole of creatinine for RBP and beta 2-microglobulin respectively (Chi-square analysis p less than 0.001), demonstrating that RBP and beta 2-microglobulin detect tubular proteinuria with equal sensitivity and specificity. ELISA and an established latex immunoassay gave well-correlated results.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3530532

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  25 in total

1.  Longitudinal studies of exposure to cadmium.

Authors:  R Armstrong; D R Chettle; M C Scott; M Blindt; H J Mason
Journal:  Br J Ind Med       Date:  1992-08

2.  Recovery of protein from urine specimens collected in cotton wool.

Authors:  G C Smith; C M Taylor
Journal:  Arch Dis Child       Date:  1992-12       Impact factor: 3.791

3.  Urinary excretion of retinol-binding protein in type 1 (insulin-dependent) diabetic patients with microalbuminuria and clinical diabetic nephropathy.

Authors:  P Pontuch; T Jensen; T Deckert; P Ondrejka; M Mikulecky
Journal:  Acta Diabetol       Date:  1992       Impact factor: 4.280

4.  Beta 2-glycoprotein-1 (apolipoprotein H) excretion in chronic renal tubular disorders: comparison with other protein markers of tubular malfunction.

Authors:  M Lapsley; P A Sansom; C T Marlow; F V Flynn; A G Norden
Journal:  J Clin Pathol       Date:  1991-10       Impact factor: 3.411

5.  Absence of effect of dipyridamole on renal and platelet function in diabetes mellitus.

Authors:  D M Gibb; D Dunger; M Levin; D Grant; P Jones; T M Barratt
Journal:  Arch Dis Child       Date:  1990-01       Impact factor: 3.791

6.  Tubular proteinuria in reflux nephropathy: post ureteric re-implantation.

Authors:  C D Goonasekera; V Shah; M J Dillon
Journal:  Pediatr Nephrol       Date:  1996-10       Impact factor: 3.714

7.  Beta 2-glycoprotein-1 (apolipoprotein H) excretion and renal tubular malfunction in diabetic patients without clinical proteinuria.

Authors:  M Lapsley; F V Flynn; P A Sansom
Journal:  J Clin Pathol       Date:  1993-05       Impact factor: 3.411

8.  Urinary excretion of beta 2-glycoprotein-1 (apolipoprotein H) and other markers of tubular malfunction in "non-tubular" renal disease.

Authors:  F V Flynn; M Lapsley; P A Sansom; S L Cohen
Journal:  J Clin Pathol       Date:  1992-07       Impact factor: 3.411

9.  Early renal effects of occupational exposure to low-level hexavalent chromium.

Authors:  T Nagaya; N Ishikawa; H Hata; A Takahashi; I Yoshida; Y Okamoto
Journal:  Arch Toxicol       Date:  1994       Impact factor: 5.153

10.  Associations of lead biomarkers with renal function in Korean lead workers.

Authors:  V M Weaver; B-K Lee; K-D Ahn; G-S Lee; A C Todd; W F Stewart; J Wen; D J Simon; P J Parsons; B S Schwartz
Journal:  Occup Environ Med       Date:  2003-08       Impact factor: 4.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.